JPMORGAN CHASE & CO - VIKING THERAPEUTICS INC ownership

VIKING THERAPEUTICS INC's ticker is and the CUSIP is 92686J956. A total of 5 filers reported holding VIKING THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of VIKING THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$79,704
-99.4%
7,200
-99.1%
0.00%
-100.0%
Q2 2023$13,689,345
+778.1%
844,500
+334.4%
0.00%
Q4 2019$1,559,000
+16.6%
194,4000.0%0.00%
Q3 2019$1,337,000
-28.1%
194,400
-12.5%
0.00%
Q2 2019$1,859,000
-27.7%
222,100
-14.1%
0.00%
-100.0%
Q1 2019$2,570,000
+391.4%
258,600
+762.0%
0.00%
Q3 2018$523,00030,0000.00%
Other shareholders
VIKING THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 57,000$630,9900.00%
JANE STREET GROUP, LLC 32,700$361,9890.00%
JPMORGAN CHASE & CO 7,200$79,7040.00%
SIMPLEX TRADING, LLC 36,200$4000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of VIKING THERAPEUTICS INC shareholders